Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal

Published byBryce Roberts Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal"— Presentation transcript:

1 Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal
Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal. Active GLP-1 and total PYY circulating concentrations over the course of the test (respectively, A and B) in obese subjects before (black circles, n = 9) and 6 wk after (open circles, n = 9) RYGBP and in obese subjects matched with the experimental group for the BMI attained 6 wk after surgery (open diamonds, n = 6). Data are expressed as mean (± sem). <sup>a</sup>, P < 0.05 and <sup>b</sup>, P < 0.01 values are indicated for comparison relative to baseline (Bonferroni). From: Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects J Clin Endocrinol Metab. 2006;91(5): doi: /jc J Clin Endocrinol Metab | Copyright © 2006 by The Endocrine Society

2 Fig. 2. Individual responses of active GLP-1 and total PYY after liquid meal intake, before RYGBP, and 6 wk after surgery. From: Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects J Clin Endocrinol Metab. 2006;91(5): doi: /jc J Clin Endocrinol Metab | Copyright © 2006 by The Endocrine Society

3 Fig. 3. Hunger and satiety VAS scores in response to a liquid test meal. Bars represent the AUC of hunger and satiety VAS scores after meal ingestion (respectively, A and B) in obese subjects before (black bar, n = 9) and 6 wk after (open bar, n = 9) RYGBP. Data are expressed as mean (± sem). <sup>a</sup>, P = 0.05 and <sup>b</sup>, P < 0.05 values are indicated for comparison between the two study time points (Wilcoxon rank test). From: Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects J Clin Endocrinol Metab. 2006;91(5): doi: /jc J Clin Endocrinol Metab | Copyright © 2006 by The Endocrine Society

4 Fig. 4. GE in obese subjects undergoing RYGBP
Fig. 4. GE in obese subjects undergoing RYGBP. Paracetamol plasma concentration over the course of the test after the ingestion of 1.5 g of paracetamol in obese subjects before (black circles, n = 6) and 6 wk after (open circles, n = 6) RYGBP. Data are expressed as mean (± sem). From: Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects J Clin Endocrinol Metab. 2006;91(5): doi: /jc J Clin Endocrinol Metab | Copyright © 2006 by The Endocrine Society

Download ppt "Fig. 1. Active GLP-1 and total PYY in response to a liquid test meal"

Similar presentations

Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.

Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.
A and B. Ghrelin secretion after bariatric surgery

A and B. Ghrelin secretion after bariatric surgery
Figure 2. Summary of trial events

Figure 2. Summary of trial events
Figure 1. Twenty-four-hour plasma ACTH concentrations in insomniacs (▪) and controls (○). The thick black line indicates the sleep recording period. The.

Figure 1. Twenty-four-hour plasma ACTH concentrations in insomniacs (▪) and controls (○). The thick black line indicates the sleep recording period. The.
Fig. 1. Baseline and 3-month infusion protocol

Fig. 1. Baseline and 3-month infusion protocol
From: Perioperative Use of Dobutamine in Cardiac Surgery and Adverse Cardiac Outcome:Propensity-adjusted Analyses Anesthes. 2008;108(6):979-987. doi:10.1097/ALN.0b013e318173026f.

From: Perioperative Use of Dobutamine in Cardiac Surgery and Adverse Cardiac Outcome:Propensity-adjusted Analyses Anesthes. 2008;108(6): doi: /ALN.0b013e f.
Fig. 1. Schematic representation of ProCT and the other CT precursors (CTpr) derived from this prohormone (i.e. NProCT, CT-CCP-I, and CCP-I). The mean.

Fig. 1. Schematic representation of ProCT and the other CT precursors (CTpr) derived from this prohormone (i.e. NProCT, CT-CCP-I, and CCP-I). The mean.
Circadian Rhythms of Women with Fibromyalgia1

Circadian Rhythms of Women with Fibromyalgia1
Fig. 1. Time line for investigations

Fig. 1. Time line for investigations
Fig. 1. Kaplan-Meir survival curves for Stoke Cushing's patients, with follow-up duration in years on the x-axis. Number of patients in each subgroup is.

Fig. 1. Kaplan-Meir survival curves for Stoke Cushing's patients, with follow-up duration in years on the x-axis. Number of patients in each subgroup is.
Chronic renal disease: A growing problem

Chronic renal disease: A growing problem
Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs9939609 of the FTO gene. The P values are for the additive model.

Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs of the FTO gene. The P values are for the additive model.
Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.

Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.
Figure 2 Top panel shows mean (SE) differences in near-final height (cm) (n = 71) in the AI, GH, and AI/GH groups regardless of length of treatment (n.

Figure 2 Top panel shows mean (SE) differences in near-final height (cm) (n = 71) in the AI, GH, and AI/GH groups regardless of length of treatment (n.
Fig. 1. Study enrollment and disposition of participants

Fig. 1. Study enrollment and disposition of participants
Fig. 2. Plasma melatonin secretion profiles for each of the eight subjects across the three conditions in the study. Profiles are shown for the entire.

Fig. 2. Plasma melatonin secretion profiles for each of the eight subjects across the three conditions in the study. Profiles are shown for the entire.
Fig. 1. Left, Total ghrelin; right, octanoylated ghrelin

Fig. 1. Left, Total ghrelin; right, octanoylated ghrelin
Volume 15, Issue 5, Pages (May 2016)

Volume 15, Issue 5, Pages (May 2016)
Volume 5, Issue 10, Pages (October 2016)

Volume 5, Issue 10, Pages (October 2016)
Fig. 4. Single total plasma 8-isoprostane levels in both controls and type 2 diabetic patients. Diabetes Induces p66shc Gene Expression in Human Peripheral.

Fig. 4. Single total plasma 8-isoprostane levels in both controls and type 2 diabetic patients. Diabetes Induces p66shc Gene Expression in Human Peripheral.

Similar presentations

Ads by Google